Pharmacogenomics is transforming medicine by uncovering how genetic variations influence drug response. This book deals with the principles of pharmacogenomics, examining its role in optimizing drug therapy and minimizing adverse effects. It explores practical applications in areas such as oncology, cardiology, and psychiatry, and discusses the ethical and regulatory considerations of integrating pharmacogenomics into clinical practice. A vital resource for clinicians and researchers, this book provides insights into the future of precision medicine.
Jacob Rose is a distinguished dermatologist specializing in pharmacogenomics and its influence on drug response in dermatological treatments. His research explores how genetic variations affect individual responses to dermatological medications, including efficacy, side effects, and optimal dosing strategies. Jacob has published extensively on the application of pharmacogenomic testing to personalize dermatological therapies, enhancing treatment outcomes and patient safety. He has developed comprehensive pharmacogenomic protocols that tailor treatments based on genetic profiles.